August 30, 2014 10:56 AM ET

Biotechnology

Company Overview of Asuragen, Inc.

Executive Profile

Matt Winkler Ph.D.

Founder, Chairman and Chief Scientific Officer, Asuragen, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Matt Winkler, Ph.D. is Co-Founder of Traitwise, Inc. Dr. Winkler founded Mirna Therapeutics, Inc. in December 2007 and serves as its Chief Scientific Officer. Dr. Winkler founded Asuragen, Inc. and serves as its Chairman and Chief Scientific Officer. He founded Ambion, Inc. in 1988 and served as its Chief Executive Officer. He is a Healthcare Advisor at Spindletop Capital and previously served as a Member of Advisory Board. He served as the Chief Executive Officer ...

Corporate Headquarters

2150 Woodward Street
Austin, Texas 78744

United States

Phone: 512-681-5200
Fax: 512-681-5201

Board Members Memberships

Founder, Chairman and Chief Scientific Officer
Founder, Executive Chairman and Chief Scientific Officer
Director

Education

PhD
University of California
BS
University of California

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Asuragen, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.